|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0030705,
umls-concept:C0138741,
umls-concept:C0220901,
umls-concept:C0441889,
umls-concept:C0596545,
umls-concept:C0600139,
umls-concept:C1366489,
umls-concept:C1417779,
umls-concept:C1522449,
umls-concept:C1522609,
umls-concept:C1554112
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1996-2-22
|
|
pubmed:abstractText |
Pretreatment prostate-specific antigen (PSA) levels may be of prognostic significance for patients with prostate cancer. Posttreatment PSA data are more limited. This study was undertaken to examine the prognostic role of pretreatment and posttreatment PSA levels in the radiation treatment of patients with carcinoma of the prostate.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0277-3732
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
65-72
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8554039-Adenocarcinoma,
pubmed-meshheading:8554039-Aged,
pubmed-meshheading:8554039-Aged, 80 and over,
pubmed-meshheading:8554039-Analysis of Variance,
pubmed-meshheading:8554039-Disease-Free Survival,
pubmed-meshheading:8554039-Humans,
pubmed-meshheading:8554039-Male,
pubmed-meshheading:8554039-Middle Aged,
pubmed-meshheading:8554039-Neoplasm Staging,
pubmed-meshheading:8554039-Prognosis,
pubmed-meshheading:8554039-Prostate-Specific Antigen,
pubmed-meshheading:8554039-Prostatic Neoplasms,
pubmed-meshheading:8554039-Retrospective Studies,
pubmed-meshheading:8554039-Treatment Outcome
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
The prognostic value of PSA levels in radiation therapy of patients with carcinoma of the prostate: the UCLA experience 1988-1992.
|
|
pubmed:affiliation |
Department of Radiation Oncology, UCLA 90095, USA.
|
|
pubmed:publicationType |
Journal Article
|
